Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · IEX Real-Time Price · USD
34.25
+0.75 (2.24%)
At close: Apr 26, 2024, 4:00 PM
34.97
+0.72 (2.10%)
After-hours: Apr 26, 2024, 6:34 PM EDT
CRBP Market Cap
CRBP has a market cap or net worth of $359.39 million as of April 26, 2024. Its market cap has increased by 755.69% in one year.
Market Cap
359.39M
Enterprise Value
358.70M
1-Year Change
755.69%
Ranking
Category
Stock Price
$34.25
Market Cap Chart
Since November 11, 2014, CRBP's market cap has increased from $75.80M to $359.39M, an increase of 374.13%. That is a compound annual growth rate of 17.88%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2024 | 351.50M | -5.74% |
Apr 24, 2024 | 372.90M | -5.83% |
Apr 23, 2024 | 396.00M | 0.10% |
Apr 22, 2024 | 395.60M | -3.91% |
Apr 19, 2024 | 411.70M | 7.41% |
Apr 18, 2024 | 383.30M | -1.69% |
Apr 17, 2024 | 389.90M | -9.64% |
Apr 16, 2024 | 431.50M | -3.75% |
Apr 15, 2024 | 448.30M | 4.60% |
Apr 12, 2024 | 428.60M | 2.12% |
Apr 11, 2024 | 419.70M | 4.85% |
Apr 10, 2024 | 400.30M | 1.81% |
Apr 9, 2024 | 393.20M | -6.69% |
Apr 8, 2024 | 421.40M | 0.48% |
Apr 5, 2024 | 419.40M | 2.57% |
Apr 4, 2024 | 408.90M | 1.21% |
Apr 3, 2024 | 404.00M | 2.77% |
Apr 2, 2024 | 393.10M | -1.38% |
Apr 1, 2024 | 398.60M | -3.18% |
Mar 28, 2024 | 411.70M | 10.32% |
Mar 27, 2024 | 373.20M | -1.61% |
Mar 26, 2024 | 379.30M | 1.44% |
Mar 25, 2024 | 373.90M | 1.99% |
Mar 22, 2024 | 366.60M | -8.42% |
Mar 21, 2024 | 400.30M | -2.60% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
iTeos Therapeutics | 383.52M |
Revance Therapeutics | 380.91M |
Anika Therapeutics | 380.66M |
Adaptive Biotechnologies | 378.69M |
Alto Neuroscience | 377.99M |
Pulse Biosciences | 372.22M |
Pacific Biosciences of California | 371.11M |
Surmodics | 369.71M |